Improvements in Axicabtagene Ciloleucel Manufacturing Result in High Delivery Success and More Predictable Turnaround Time for Patients with Relapsed/Refractory Large B-Cell Lymphoma
Year: 2024
Type: conference-abstract
Source: Blood
Authors: David B. Miklos, Wike Tong, Eric Kim, Brandon Kerr, Morgan Neuwirth, Laura Alquist, Clare Spooner
Institution: Stanford University
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405034722